Sorafenib as a classic targeted therapeutic agent for advanced hepatocellular carcinoma (HCC) is still facing a severe challenge of drug resistance. Our previous studies showed that the up-regulation of autophagy by FOLR1 expression is the cause of drug resistance in HCC cells, but the detailed mechanism by which FOLR1 reduces the sensitivity of sorafenib remains unclear. In this study, we found that the ERK signaling pathway inhibited by sorafenib was reactivated in the FOLR1 overexpression HCC cells in the presence of folic acid. Mechanistically, the high expression of FOLR1 enhanced the ability of cells to uptake folic acid, which increased the binding ability of FOLR1 to SRC protein and SRC DNA promoter region to enhance the expression level of SRC kinase, leading to ERK signaling pathway activation originally inhibited by sorafenib in HCC cells, which provides a new therapeutic approach and therapeutic target and strategy for HCC patients.
Zhang, et al. “FOLR1 promotes sorafenib resistance by enhancing folic acid uptake to activate SRC/ERK signaling pathway in hepatocellular carcinoma.” Biology Direct, 2026. doi:10.1186/s13062-026-01054-1.
@article{Zhang2026,
title = {FOLR1 promotes sorafenib resistance by enhancing folic acid uptake to activate SRC/ERK signaling pathway in hepatocellular carcinoma},
author = {Zhang and Kun and Cui and Xulian and Liu and Li and Xia and Yu and Zhao and Hui and Hu and Wenquan and Zhao and Baofeng and Zhang and Lihua},
journal = {Biology Direct},
year = {2026},
doi = {10.1186/s13062-026-01054-1},
url = {https://doi.org/10.1186/s13062-026-01054-1}
}
Mesenchymal stem cells (MSCs) have emerged as promising therapeutic agents in regenerative medicine, with their therapeutic effects increasingly attributed to intercellular communication and microenvironmental regulation rather than...
Background Scleral remodeling with myofibroblast activation and extracellular matrix (ECM) degradation drives myopia, but mechanisms remain unclear. This study explored USP33’s role and its regulatory network. Methods We analyzed GEO...
Background Lung cancer is one of the leading causes of cancer-related mortality worldwide. Understanding the molecular mechanisms underlying lung cancer progression is critical for identifying novel therapeutic targets. This study...